Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy

NCT01014325 is registered in ClinicalTrials.gov with Roxall Medizin as lead sponsor.

NCT NCT01014325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01014325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
Lead sponsor
Roxall Medizin
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2016
Completion date
September 30, 2017
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis